- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06147440
Different Dietary Patterns
April 10, 2025 updated by: Prof. Dr. Ina Bergheim, University of Vienna
Different Dietary Patterns: Investigations in Healthy Participants
The aim of the present study is to determine the effects of different standardized dietary patterns on general health markers, intestinal function, immune response and affective processes/ cognitive skills in healthy subjects.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Vienna, Austria
- Recruiting
- University of Vienna
-
Contact:
- Ina Bergheim, Prof. Dr.
- Phone Number: +431427754981
- Email: ina.bergheim@univie.ac.at
-
Contact:
- Annette Brandt, Dr.
- Phone Number: +43427754984
- Email: annette.brandt@univie.ac.at
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- BMI between 18.5 kg/m² und 24.9 kg/m²
Exclusion Criteria:
- Chronic inflammatory diseases
- Metabolic diseases
- Viral or bacterial infections in the last 3 weeks
- Allergic reactions in the last 3 weeks
- Intake of anti-inflammatory drugs
- Malignant diseases
- Pregnancy and lactation
- Smoking
- Alcohol consumption > 10 g/d for women and > 20 g/d for men
- Drug consumption
- Vegetarian or vegan diet
- Food intolerances
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Dietary pattern 1
Participants receive a standardized diet following the recommendation of DACH nutrition societies.
|
Participants receive diets following different dietary patterns for 1 week.
|
|
Experimental: Dietary pattern 2
Participants receive a standardized diet following the recommendation of DACH nutrition societies.
|
Participants receive diets following different dietary patterns for 1 week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in parameters of intestinal barrier function
Time Frame: 1 week
|
Changes in TLR ligand serum levels
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in parameters of immune response
Time Frame: 1 week
|
Changes in concentration of Interleukin-6 in cell culture supernatant of stimulated immune cells
|
1 week
|
|
Changes in blood lipid levels
Time Frame: 1 week
|
Changes in triglyceride, cholesterol levels [mg/dl]
|
1 week
|
|
Changes in cognitive skills
Time Frame: 1 week
|
Assessment of cognitive processes using computer-based psychological tasks (Stroop effect; calculation of differences in response times to incongruent vs. congruent word-color associations)
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 20, 2023
Primary Completion (Estimated)
October 1, 2025
Study Completion (Estimated)
December 1, 2025
Study Registration Dates
First Submitted
October 31, 2023
First Submitted That Met QC Criteria
November 23, 2023
First Posted (Actual)
November 27, 2023
Study Record Updates
Last Update Posted (Actual)
April 15, 2025
Last Update Submitted That Met QC Criteria
April 10, 2025
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UVienna22
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endotoxemia
-
Petrovsky National Research Centre of SurgeryRecruitingMultiple Organ Dysfunction With Severe EndotoxemiaRussian Federation
-
Radboud University Medical CenterUMC UtrechtCompletedSepsis, Endotoxemia, ImmunosuppressionNetherlands
-
Alteco Medical ABWithdrawnSuspected or Diagnosed Endotoxemia Casued by Gram-negative Bacteria
-
DaniscoCompleted
-
Ohio State UniversityCompletedMetabolic Syndrome | Metabolic EndotoxemiaUnited States
-
Radboud University Medical CenterCompleted
-
Radboud University Medical CenterCompleted
-
Radboud University Medical CenterCompleted
-
Radboud University Medical CenterCompleted
-
Iowa State UniversityCompleted
Clinical Trials on Dietary intervention
-
University of ViennaCompletedEndotoxemia | Dietary HabitsAustria
-
Azienda Ospedaliero-Universitaria CareggiRecruiting
-
Brown UniversityNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Brown UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
University Hospital, Strasbourg, FranceRecruitingDigestive Cancer | UndernourishedFrance
-
Josephine Ford Cancer CenterNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRectal Cancer | Colon Cancer | Cancer Survivor | Colorectal Adenocarcinoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
University of South CarolinaAcademy of Nutrition and DieteticsCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Terminated